Skip to content
Clinical Trials – home
United KingdomBack to the United Kingdom

Clinical trials in Grengegorman – page 17

334 clinical trials in Grengegorman, United Kingdom. Every trial is listed in the EU Clinical Trials Register and updated daily.

Grengegorman at a glance
334
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

334 trials in Grengegorman

Open in trial search

Study of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Mediar Therapeutics Inc.

Study of ifinatamab deruxtecan alone or in combination with other treatments for patients with metastatic castration-resistant prostate cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Merck Sharp & Dohme LLC

Colitis ulcerative

Not recruiting

Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Celgene Corp.

Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Efanesoctocog Alfa
  • Sponsor:Swedish Orphan Biovitrum AB (publ)

Breast cancer+1

Not recruiting

Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Pfizer Inc.

Study on Treating Osteogenesis Imperfecta in Patients Using Teriparatide and Zoledronic Acid

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Carbonate
  • Sponsor:NHS Lothian

Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Acasunlimab
  • Sponsor:Genmab A/S

Study on the Safety and Effectiveness of Taladegib for Patients with Idiopathic Pulmonary Fibrosis

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Taladegib
  • Sponsor:Endeavor Biomedicines Inc.

Asthma

Not recruiting

Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB

Obesity+1

Not recruiting

Study on Semaglutide for Patients with Obesity and Resistant Hypertension to Improve Blood Pressure Control

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Trinity College Dublin

Study of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Immutep

Clinical research in Grengegorman

What the registry says about research in the country

01 Ophthalmology Research

Innovative clinical trials focusing on treating myopia progression in pediatric patients, exploring new therapeutic approaches for vision care management.

  • Pediatric Vision Care
  • Myopia Management
  • Visual Development

Research efforts aim to evaluate novel treatments for controlling childhood nearsightedness, potentially offering new solutions for young patients struggling with progressive vision changes.

02 Pediatric Eye Care

Dedicated studies examining the effectiveness of new ophthalmic solutions in managing vision disorders among children, with a focus on long-term treatment outcomes.

  • Vision Development
  • Early Intervention
  • Treatment Safety

These trials represent significant advances in pediatric ophthalmology, investigating safe and effective interventions for young patients with progressive vision conditions.

03 Vision Science

Comprehensive research into vision disorders affecting young populations, utilizing controlled clinical studies to advance understanding and treatment options.

  • Clinical Efficacy
  • Treatment Innovation
  • Long-term Outcomes

The studies emphasize the importance of early intervention and monitoring in pediatric vision care, with potential implications for future treatment protocols.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.